Asma Sabermahani - Concepedia

Author

Asma Sabermahani

Kerman University of Medical Sciences ORCID

Also Known As

A Sabermahani, Asma Sabermahani, Sabermahani,

Publications

218

Citations

H-Index

Concepts

All Affiliations

Kerman University of Medical Sciences Iran University of Medical Sciences

About

Asma Sabermahani is an author at Kerman University of Medical Sciences specializing in medicine, patient safety, and health policy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	54
2	Public Health	2	2	40
3	Nursing	1	1	14
4	Biostatistics	1	1	21
5	Emergency Medicine	1	1	14

Asma Sabermahani

Publications

169

Citations

H-Index

Page 1

	Year	Citations
Provincial human development index, a guide for efficiency level analysis: the case of iran. Asma Sabermahani, Mohsen Barouni, Hesam Seyedin, PubMed	2013	38
Factors Affecting Health Care Utilization in Tehran Soraya Nouraei Motlagh, Asma Sabermahani, Mohsen Asadi Lari, Global Journal of Health Science	2015	33
Markov's Modeling for Screening Strategies for Colorectal Cancer Mohsen Barouni, Mohammad Hassan Larizadeh, Asma Sabermahani, Asian Pacific Journal of Cancer Prevention Colon Cancer ScreeningEpidemiology Of CancerPreventive MedicineOncologyCancer Detection	2012	21
Gender Inequality Index Appropriateness for Measuring Inequality Elham Amin, Asma Sabermahani Journal of Evidence-Informed Social Work	2017	20
Out-of-Pocket Costs and Importance of Nonmedical and Indirect Costs of Inpatients Asma Sabermahani, Mohammad Jafari Sirizi, Farzaneh Zolala, Value in Health Regional Issues Family MedicineHospitalizationIndirect CostsHealthcare ValueHealth Policy	2021	19
Hospital Nurses’ Disaster Competencies Mahdiye Nejadshafiee, Moghadameh Mirzaee, Fatemeh Aliakbari, Trauma Monthly NursingDisaster Core CompetencyMental Health NursingDisaster CompetenciesDisaster Management	2020	14
Factors Affecting Fertility Rate in Iran (Panel Data 1966-2013): A Survey Study. Asma Sabermahani, Reza Goudarzi, Sarah Nasiri PubMed	2017	13
Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study Mohammad Tasavon Gholamhoseini, Heidar Sharafi, Helena Hiemisch Lobo Borba, BMJ Open	2022	11

Page 1